IntraMed - Artículos - Prevención de la infección neonatal por estreptococo grupo B
Organismo de prevención de enfermedades de Canadá | 12 MAR 03
Prevención de la infección neonatal por estreptococo grupo B
Los factores de riesgo para la infección incluyen el parto prematuro, la rotura prematura de membranas mayor a 18 horas, la fiebre materna, la bacteriuria positiva.
Autor: Canadian Task Force on Preventive Health Care. Fuente: Artículo original 
INDICE:  1. Desarrollo | 2. Evidencia y resumen clínico | 3. Bibliografía
Bibliografía
1. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein JO, editors. Infectious disease of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders. 1995. p. 980-1054.

2. Davies HD, Raj S, Adair C, Robinson J, McGeer A, Group TA. Population-based active surveillance for neoantal group B streptococcal infections in Alberta: implications for vaccine formulation. Pediatr Infect Dis J 2001;20:879-84.

3. Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996;174:1354-60.

4. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Mor Mortal Wkly Rep CDC Surveill Summ 1992;41:25-32.

5. Goldenberg E, Davies HD, Landry L, the Toronto GBS study group. Hospital prevention policies and the incidence of early onset neonatal group B streptococcal disease [abstract no 1879]. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1998 Sept 24-28; San Diego.

6. Scharg SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.

 7. Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31-6.

8. Noya FJ, Rench MA, Metzger TG, Colman G, Naidoo J, Baker CJ. Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987;155:1135-44.

9. Berkowitz K, Regan JA, Greenberg E. Antibioitic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 1990;28:5-7.

10. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-9.

11. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-61.

12. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-83.

13. Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM. Antibiotic use in pregnancy and drug-resistant infant sepsis. Am J Obstet Gynecol 1999; 181: 816-21.

14. Society of Obstetricians and Gynaecologists. Statement on the prevention of early-onset group B streptococcal infections in the newborn. J Soc Obstet Gynaecol 1997;19:751-8.

15. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996;45(RR-7):1-24

16. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96

17. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy: ACOG's recommendations. ACOG Newsl 1993;37:1.

18. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcus disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.

19. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:583-7

20. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. Eur J Obstet Gynecol Reprod Biol 1991;40:57-62.

21. Morales WJ, Lim D. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test. Am J Obstet Gynecol 1987;157:13-6.

22. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcomes of newborns. Pediatrics 1994;93:631-5.

23. Gibbs RS, McDuffie RS Jr, McNabb F, Fryer GE, Miyoshi T, Merenstein G. Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet Gynecol 1994;84:496-500.

24. Allardice JG, Baskett TF, Seshia MM, Bowman N, Malazdrewicz R. Perinatal group B streptococcal colonization and infection. Am J Obstet Gynecol 1982;142:617-20.

25. Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Aust NZ J Obstet Gynecol 1991;31:119-22

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014